Patent · US Active

Panel of micrornas that silence the MCL-1 gene and sensitize cancer cells to ABT-263

US8742083B1 · kind B1 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2010
Grant dateJun 3, 2014
Priority date
Expiry dateMar 18, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

MicroRNAs (miRNAs) that sensitize cancer cells to Bcl-2 family protein inhibitors are identified and described. Oligonucleotide panels, arrays and methods using the sensitizing miRNAs are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.